Literature DB >> 17177057

Cornea as a tissue reservoir of Trypanosoma cruzi.

Leidi Herrera1, Clara Martínez, Hernán Carrasco, Ana Maria Jansen, Servio Urdaneta-Morales.   

Abstract

Trypanosoma cruzi causal agent of Chagas' disease is a paninfective parasite of mammals transmitted through skin fecal contamination by Triatominae vectors. Studies of alternative routes for infection are scarce; therefore, eye infection should be important, because of the eye's high blood irrigation and brain proximity, as port of entry of the parasite. Trypanosoma cruzi parasites and/or their genetic material in ocular and adjacent muscle tissues were studied in batches of six NMRI mice (15 g) and Trichomys apereoides, an ancient caviomorph (250 g) inoculated with T. cruzi metacyclics from Brazilian (2) and Venezuelan (3) isolates genetically typified as T. cruzi I and II. Two animals/batch in the acute or chronic phase were killed and necropsies of cardiac and skeletal muscles, eyeball, and surrounding ocular muscle were processed for hematoxylin-eosine staining. Tissue parasitism was determined. DNA of the digested sections of the eyeball (5-10 mum) was extracted for T. cruzi k-DNA amplification by PCR, with S35 and S36 primers. The PCR products were analyzed. The average of maximum values of parasitemia of all infected animals was of 10(5) trypomastigotes/ml blood. Skeletal muscle and heart were colonized in patent infection for all isolates. Amastigote nests were found in corneal tissue of 2/3 of the used isolates and adjacent ocular muscle and connective tissue were parasitized. Trypanosoma cruzi k-DNA (330-bp band) was observed in ocular tissue of 4/6 of the isolates studied in both animal models. Investigations concerning infection of the eye globe tissues by T. cruzi are extremely scarce. The presence of stages of T. cruzi and/or its genetic products in ocular tissues indicate a broad colonization from a systemic infection. The results show the ocular environment as a possible appropriate microniche for T. cruzi and emphasize the risk of transmitting T. cruzi by ocular fluids and by parasitized cornea through transplants.

Entities:  

Mesh:

Year:  2006        PMID: 17177057     DOI: 10.1007/s00436-006-0403-9

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  20 in total

1.  Recommendations from a satellite meeting.

Authors: 
Journal:  Mem Inst Oswaldo Cruz       Date:  1999       Impact factor: 2.743

2.  Trypanosoma cruzi: distinct patterns of infection in the sibling caviomorph rodent species Thrichomys apereoides laurentius and Thrichomys pachyurus (Rodentia, Echimyidae).

Authors:  André Luiz Rodrigues Roque; Paulo Sérgio D'Andrea; Gisele Braziliano de Andrade; Ana Maria Jansen
Journal:  Exp Parasitol       Date:  2005-09       Impact factor: 2.011

Review 3.  Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue.

Authors:  J E Lane; D Olivares-Villagomez; C L Vnencak-Jones; T L McCurley; C E Carter
Journal:  Am J Trop Med Hyg       Date:  1997-06       Impact factor: 2.345

4.  Genetic Variability of Trypanosoma cruzi:Implications for the Pathogenesis of Chagas Disease.

Authors:  A M Macedo; S D Pena
Journal:  Parasitol Today       Date:  1998-03

5.  Experimental Trypanosoma cruzi infection in beagle puppies. The effect of variations in the dose and source of infecting trypanosomes and the route of inoculation on the course of the infection.

Authors:  P D Marsden; J W Hagstrom
Journal:  Trans R Soc Trop Med Hyg       Date:  1968       Impact factor: 2.184

6.  Genital lesions associated with visceral leishmaniasis and shedding of Leishmania sp. in the semen of naturally infected dogs.

Authors:  S A Diniz; M S Melo; A M Borges; R Bueno; B P Reis; W L Tafuri; E F Nascimento; R L Santos
Journal:  Vet Pathol       Date:  2005-09       Impact factor: 2.221

7.  Trypanosoma cruzi infection in wild mammals of the National Park 'Serra da Capivara' and its surroundings (Piaui, Brazil), an area endemic for Chagas disease.

Authors:  L Herrera; P S D'Andrea; S C C Xavier; R H Mangia; O Fernandes; A M Jansen
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-05       Impact factor: 2.184

Review 8.  Infectious disease issues in xenotransplantation.

Authors:  R S Boneva; T M Folks; L E Chapman
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

9.  Trypanosoma cruzi: skin-penetration kinetics of vector-derived metacyclic trypomastigotes.

Authors:  J P Schuster; G A Schaub
Journal:  Int J Parasitol       Date:  2000-12       Impact factor: 3.981

10.  Detection of herpes simplex virus DNA in human tear film by the polymerase chain reaction.

Authors:  S Yamamoto; Y Shimomura; S Kinoshita; K Nishida; R Yamamoto; Y Tano
Journal:  Am J Ophthalmol       Date:  1994-02-15       Impact factor: 5.258

View more
  4 in total

Review 1.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

2.  Trypanosoma cruzi: experimental parasitism in the central nervous system of albino mice.

Authors:  Antonio Morocoima; Grace Socorro; Régulo Avila; Ana Hernández; Solángel Merchán; Diana Ortiz; Gabriela Primavera; José Chique; Leidi Herrera; Servio Urdaneta-Morales
Journal:  Parasitol Res       Date:  2012-08-07       Impact factor: 2.289

Review 3.  Chagas' disease: an emergent urban zoonosis. The caracas valley (Venezuela) as an epidemiological model.

Authors:  Servio Urdaneta-Morales
Journal:  Front Public Health       Date:  2014-12-03

4.  Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.

Authors:  Anthony W Ashton; Shankar Mukherjee; F N U Nagajyothi; Huan Huang; Vicki L Braunstein; Mahalia S Desruisseaux; Stephen M Factor; Lillie Lopez; Joan W Berman; Murray Wittner; Philipp E Scherer; Valerie Capra; Thomas M Coffman; Charles N Serhan; Katherine Gotlinger; Kenneth K Wu; Louis M Weiss; Herbert B Tanowitz
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.